Showing 13,191 - 13,200 of 13,419
States that although Japan’s pharmaceutical industry has succeeded in steadily advancing its total sales revenues in recent years, its market share of worldwide volume has actually retreated slightly. Its major competitor continues to be the USA, while its three top European rivals: Germany,...
Persistent link: https://www.econbiz.de/10014723227
Purpose – This study aims to increase understanding of the factors that affect retail pharmacy performance. This paper investigates how various product-, store-, customer- and competitor characteristics affect over-the-counter (OTC) drug sales and thus store performance....
Persistent link: https://www.econbiz.de/10014723945
How do you ensure that representatives can confidently sell a complex product to a sophisticated audience? This was the problem faced by a European pharmaceutical company whose salesforce and managers needed to understand the features and benefits of its novel “high tech” molecule – and be...
Persistent link: https://www.econbiz.de/10014754966
generic pharmaceuticals during the first four years after the reform. The results also show that the price adjustment was not …
Persistent link: https://www.econbiz.de/10005197987
This paper studies the impact of the strict patent regime on the patenting activity of Indian pharmaceutical firms and finds that patenting activity of these firms has increased after the signing of TRIPs. The study is conducted for 65 pharmaceutical firms for the period 1991 to 2004 using...
Persistent link: https://www.econbiz.de/10005481458
Economics at the Federal Trade Commission (FTC) supports both the competition and consumer protection missions of the agency. In this year’s essay we discuss a range of activities focusing on data-intensive antitrust cases in the hospital and consumer products industries. We also discuss our...
Persistent link: https://www.econbiz.de/10005705025
During the past 20 years, the world pharmaceutical industry has experienced a dramatic increase in R&D intensity. We apply and extend a model developed by Grabowski and Vernon (2000, Journal of Evolutionary Economics, <Emphasis Type="Bold">10, 201–215) with a pooled data sample of the 15 publicly listed Japanese...</emphasis>
Persistent link: https://www.econbiz.de/10005705054
Persistent link: https://www.econbiz.de/10005705057
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Under conservative assumptions, our estimates imply that the average annual increase in life expectancy of the entire...
Persistent link: https://www.econbiz.de/10005711017
Persistent link: https://www.econbiz.de/10005719403